Top 50 Health Care VC Funds & Investors (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
270 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Alumni Ventures
VC Fund
|
161 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.4M–$86M |
|
General Catalyst
VC Fund
|
150 | United States, United Kingdom, India | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.5M–$140M |
|
Bpifrance
VC Fund
|
147 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $713k–$34M |
|
Khosla Ventures
VC Fund
|
140 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
StartUp Health
VC Fund
|
140 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
ARCH Venture Partners
VC Fund
|
138 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.8M–$230M |
|
Innova Memphis
VC Fund
|
133 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device | $25k–$1.7M |
|
OrbiMed
VC Fund
|
132 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$149M |
|
Antler
VC Fund
|
121 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $101k–$29M |
|
Qiming Venture Partners
VC Fund
|
121 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
F-Prime
VC Fund
|
118 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$130M |
|
New Enterprise Associates
VC Fund
|
118 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.3M–$103M |
|
Right Side Capital Management
VC Fund
|
117 | United States, Canada, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, SaaS, Health Care | $18k–$2M |
|
Gaingels
VC Fund
|
110 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.5M–$100M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
104 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$40M |
|
Andreessen Horowitz
VC Fund
|
101 | United States, United Kingdom, Brazil | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.5M–$107M |
|
Sofinnova Partners
VC Fund
|
100 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Alexandria Venture Investments
VC Fund
|
96 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
Novo Holdings
VC Fund
|
94 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $8M–$130M |
|
Polaris Partners
VC Fund
|
93 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$100M |
|
Rock Health Capital
VC Fund
|
90 | United States, Denmark | Seed, Series A, Series B | Health Care, Software, Medical | $20k–$63M |
|
Connecticut Innovations
VC Fund
|
86 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $200k–$25M |
|
Versant Ventures
VC Fund
|
86 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
Google Ventures
VC Fund
|
85 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1M–$106M |
|
Atlas Venture
VC Fund
|
85 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.2M–$115M |
|
Lux Capital
VC Fund
|
84 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.8M–$150M |
|
Calm/Storm VC
VC Fund
|
81 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $478k–$18M |
|
First Round Capital
VC Fund
|
80 | United States, Canada, India | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.1M–$60M |
|
Canaan Partners
VC Fund
|
76 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care | $5M–$75M |
|
SV Aangel
VC Fund
|
76 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Internet | $1M–$107M |
|
RA Capital Management
VC Fund
|
75 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $26M–$235M |
|
Enterprise Ireland
VC Fund
|
74 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$12M |
|
BioVenture
VC Fund
|
74 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.6M–$73M |
|
Accel
VC Fund
|
73 | United States, India, United Kingdom | Series A, Series B, Seed | Software, SaaS, Information Technology | $1.5M–$70M |
|
Founders Fund
VC Fund
|
73 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.5M–$105M |
|
Global Founders Capital
VC Fund
|
72 | United States, Germany, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $637k–$33M |
|
BoxGroup
VC Fund
|
72 | United States, Mexico, Canada | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.5M–$90M |
|
TEDCO
VC Fund
|
71 | United States, Canada, United Kingdom | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
8VC
VC Fund
|
70 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.7M–$175M |
|
Portfolia
VC Fund
|
70 | United States, Canada, Argentina | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$59M |
|
Kurma Partners
VC Fund
|
68 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$80M |
|
HSG
VC Fund
|
68 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
Lilly Asia Ventures
VC Fund
|
68 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$259M |
|
MPM Capital
VC Fund
|
67 | United States, Canada, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$116M |
|
FJ Labs
VC Fund
|
66 | United States, Brazil, United Kingdom | Seed, Series A, Series B | Software, E-Commerce, Financial Services | $1.4M–$65M |
|
Third Rock Ventures
VC Fund
|
66 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$150M |
|
M Ventures
VC Fund
|
66 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
5AM Ventures
VC Fund
|
65 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $13M–$110M |
|
BioAdvance
VC Fund
|
65 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical | $200k–$40M |
| Access all 25681 VC funds in Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1413
- Round size: Seed $1.4M–$10M; Series A $5.2M–$37M; Series B $12M–$86M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Polygraf — AI Usage Behavioral Control Layer - Polygraf sits directly between enterprise users, agents, and AI systems to inspect every AI interaction before data leaves your security boundary.
- Operant — Own OperantAi.com today. Secure checkout and guided transfer support. No hidden fees.
- Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
Investing in powerful, positive change that endures
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 1516
- Round size: Seed $1.5M–$18M; Series A $5.5M–$65M; Series B $12M–$140M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Goodstack — Goodstack is a SaaS and fintech platform for managing charitable donations.
- Endo Health — Reverse Your Diabetes With a Game
- Windsurf — Windsurf offers an AI coding assistant designed to enhance developers' productivity. The platform features an integrated development environment that simplifies coding tasks and streamlines workflows. It supports multiple operating systems, including Mac, Windows, and Linux, making it accessible to a wide range of users. Windsurf provides afree version for individual developers, while teams can access additional features through an enterprise offering. This flexibility allows users to choose the option that best suits their needs. By focusing on usability and functionality, Windsurf aims to improve its users' overall coding experience.
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1039
- Round size: Seed $713k–$6.9M; Series A $2.6M–$34M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Hiqute Diamond — High quality diamond plates for high-end applications
- Pitchy — Create professional videos without technical expertise. Our online video editor helps you easily make business videos.
- Siteflow — For many years digital transformation of the manufacturing industry has been underway. However, for regulated industries and operations that combine complex reporting workflows, project manufacturing and mobility for the field, few digital solutions meet the expectations. As a result, on those sites, tools and work methods haven’t changed so muchthe past decades while quality and safety requirements have exploded.That is around those challenges that professionnals from the nuclear industry, special works and software experts have gathered, to create Siteflow, the first cloud-based field service management software designed for complex operations (Nuclear, Oil&Gas…).A solution designed for end-userBeyond technical specificities from those markets, we have leveraged learnings from industries that have already been through digital transformation: every time user acceptance is key to make those challenging projects a success.This is why at Siteflow, our obsession is to design the most simple interfaces, and functionalities that bring value directly for our users, in order to simplify their daily tasks, to ease collaboration with their colleagues and to help them focus on what really matters.A change management program to facilitate digital transformationAs we all know, the choice of a software solution is just part of the puzzle to implement a digital transformation program. Organizations need to be re-designed as day-to-day activities of engineers, project managers and operators are directly concerned. Based upon our experience, we help our customers for a smooth transition to operational excellence.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1075
- Round size: Seed $2M–$16M; Series A $5.5M–$44M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
- Siolta Therapeutics — Siolta Therapeutics is harnessing science from the human microbiome to design next-generation microbial therapeutics. Learn more.
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 381
- Round size: Series A $7.8M–$212M; Series B $13M–$230M; Series C $15M–$175M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Bitterroot Bio — Bitterroot Bio is pioneering the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health.
- TFC Therapeutics — TFC Therapeutics is a biotechnology company developing novel biologics to target and eliminate key drivers of cancer.
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: United States, Argentina, United Kingdom
Investor stats
- Total investments: 251
- Round size: Seed $50k–$1.7M; Pre-Seed $25k–$1.3M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 581
- Round size: Series A $10M–$116M; Series B $24M–$149M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Galecto — Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.
- Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
- Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1090
- Round size: Seed $371k–$5.8M; Pre-Seed $101k–$1.1M; Series A $4.6M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- not8 — not8 is a SaaS platform that helps digital agencies and IT companies save those hours and increase employee productivity by up to 15% by moving all the conversations "inside the product".
- Peckish — Enabling sustainable growth for F&B business by automating inventory management and optimising the supply chain
- Cloud Cycle — Globally we produce over 10 billion tons of concrete each year, its the second most consumed material on the planet behind wate and is responsible for upto 10% of global CO2 emissions. Around 5% of all concrete produced goes to waste, this waste in the UK alone costs around £400 million.Cloud Cycle has developed an on-truck device and sensorarray which feeds our cloud platform to ensure concrete meets specification & prevents waste. Even when surplus does still occur, our marketplace for the local on-sale of surplus concrete will find a buyer. We aim to save industry billions whilst reducing global CO2 by 1%.We are using advanced technology & the circular economy to transform the concrete industry.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 730
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- SPEEDIANCE — Speediance specializes on smart self-serviced gym equipment. The company develops smart fitness equipment and an online platform to provide training guidance and courses about strength training, enabling individual users to connect with the workout community and have better home workout experiences.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 415
- Round size: Series A $9.2M–$87M; Series B $16M–$130M; Series C $22M–$115M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- NOCD — Reduce OCD severity significantly in just 10 weeks on average. Schedule a FREE phone call with team, and we'll connect you with a licensed OCD Therapist.
- ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
- Bicara Therapeutics — At Bicara, we are attacking cancer head-on by combining the precision of targeted therapies with the power of tumor-microenvironment modulators to create better medicines for patients.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1539
- Round size: Series A $5.3M–$60M; Series B $10M–$80M; Series C $13M–$103M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $2.8B in 2022
Portfolio highlights
- triValence —
- Radiology Partners — Radiology Partners is the leading radiology practice in the U.S., consisting of a network of of radiology practices serving hospitals and other healthcare facilities across the nation.
- Regulus Therapeutics — Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteinsbut instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 692
- Round size: Seed $18k–$2M; Pre-Seed $50k–$416k; Convertible Note $50k–$500k
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Cohley — Cohley is a content marketing platform focusing on user generated content, visual asset creation, and text review generation. Streamline your content generation today!
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
- Ceemo — Ceemo - Ceemo's simple 5-step quiz generates a complete brand & all the foundational marketing assets your small biz needs in just 10 minutes or less.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 728
- Round size: Seed $1.5M–$8M; Series A $6M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- BQP — BosonQ Psi Pvt. Ltd. (BQP) is a state-of-the-art SaaS-based enterprise software venture leveraging the power of Quantum computing to speed up virtual simulations of Multiphysics and Computer-Aided Engineering (CAE) nature. BosonQ Psi is at the forefront of this quantum revolution. Our vision is to become the premier multiphysics simulation softwareusing quantum computing. Our world-class software suite will include computational science fields of fluid dynamics, structural dynamics, thermal, chemical, and aeroacoustics. With such an innovative product, we will revolutionize the computational world by enabling high-fidelity simulations that are impossible to solve with current computing technology. Further, this product will aid aerospace, automotive, energy, manufacturing, biotechnology, civil engineering, and astrophysics industries in saving millions of dollars by reducing long turnaround times of simulations used in the design process and give higher accuracy to make significant design changes for giving rise to the next generation of an electric car, eVTOL, skyscraper, or even Mars Rover.The possibility to harness the power of quantum computers is endless, and we at BQP thrive on pushing the boundaries of quantum computing technologies to serve our clients. We have made it our mission to bring these possibilities into the hands of every person - from a researcher to a scientist, from a professor to a student. Our name, BosonQ Psi, pays tribute to the great Indian physicist Dr. Satyendra Nath Bose, after whose name the elementary particle in quantum mechanics, Boson, was named and further incorporates the fundamental quantity that describes the state of the quantum particle - Psi, thus symbolizing the company's fundamental goal to contribute in India's goal to be the leader in the Quantum realm and also become a global leader in Quantum paradigm shift in coming years.
- BetterBrand — Designing a Better future of food. The Better Bagel features Fewer Carbs and More Protein.
- Sharper Sense — Neuromodulation for Clear Senses
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 550
- Round size: Seed $909k–$7.7M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
- FinMarie — FinMarie is an online financial platform for women for women in Germany. The firm supports clients with financial and wealth management projects and helps them find solutions appropriate for their personal situation.
- GeneQuine Biotherapeutics — GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 1608
- Round size: Seed $1.5M–$15M; Series A $9M–$52M; Series B $16M–$107M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Slack — Slack is a global collaboration hub that makes people’s working lives simpler, more pleasant, and more productive. From global Fortune 100 companies to corner markets, businesses, and teams of every kind use Slack to bring the right people together with all the right information. Slack is headquartered in San Francisco California and has nineoffices around the world.
- Wiz — Organizations of all sizes and industries use Wiz to rapidly identify and remove the most critical risks in AWS, Azure, GCP, and Kubernetes so they can build faster and more securely.
- Setpoint.io — Originators, Asset Managers and Lenders use Setpoint's technology and capital to power asset-backed transactions.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 244
- Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $22M–$150M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
- Marvin Health — Marvin is a mental health service for physicians. We're ending the one-size-fits-all approach to teletherapy, helping you to set a teletherapy action plan.
- Affinia Therapeutics — Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 331
- Round size: Series A $8M–$118M; Series B $12M–$130M; Series C $30M–$115M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- AlloCure — AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries. It offers biological therapeutics for acute kidney injuries. AlloCure is based in Burlington, Massachusetts. It has operations in Salt Lake City, Utah, and Hamburg, Germany.The company isdedicated to the development of off-the-shelf biological therapies to treat serious and debilitating diseases that afflict millions of people around the world. AlloCure's unique technology uses processed cells derived from human bone marrow to treat a wide variety of diseases. AlloCure was founded on the unique and proprietary technology developed by Dr. Christof Westenfelder and Dr. Axel Zander. Westenfelder and Zander are world-renowned scientists who have dedicated their careers to developing effective therapies for kidney disease. AlloCure has operations in Salt Lake City Utah and Hamburg Germany.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Cleveland Diagnostics — Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers - early on, when cancer is still curable.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 448
- Round size: Series A $4.5M–$80M; Series B $7M–$100M; Series C $10M–$100M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $182M in 1998
Portfolio highlights
- Livara Health — The SpineZone solution works with the body's inherent ability to heal back and joint pain without surgery, injection, or opioids.
- Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
- Hydra Biosciences — Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra's proprietary high throughput screening platforms enable the company to identify and develop drug candidates that addresssignificant unmet medical needs.Hydra's ion channel drug discovery program is currently focused on channels implicated in pain, inflammation, and cardiovascular disease. Hydra's intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium, or potassium voltage-gated channels Hydra's novel ion channels provide the potential to develop selective and safer ion channel drugs.Hydra has raised significant financing from blue-chip investors since its inception. This prominent group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures.
Rock Health Capital is a full-service seed fund that invests in and supports startups working in digital health. The company invests in entrepreneurs working at the intersection of healthcare and technology. Rock Health Capital is a digital health-focused investment firm.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark
Investor stats
- Total investments: 113
- Round size: Seed $20k–$4.2M; Series A $4.7M–$34M; Series B $8M–$63M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Burst — Burst | FSA & HSA Checkout, Reimbursements, and LMNs anywhere
- Pear Suite — Pear Suite empowers community health workers with technology, education, and community, helping them do their best work and serve their communities.
- Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 246
- Round size: Seed $200k–$5M; Series A $2.4M–$25M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Device42 — Device42 sets the standard as the most comprehensive, agentless discovery and dependency mapping solution, spanning from legacy mainframes to cloud containers.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 280
- Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Nested Therapeutics — Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.
- Dualitas Therapeutics — Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders and other conditions. With a growing collection of innovative cell surface proximity engagers and our in-house DualScreen™ discovery engine, our pipeline
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1011
- Round size: Seed $1M–$13M; Series A $5.4M–$86M; Series B $15M–$106M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
- Nearby — KANTINSLOT adalah sebuah situs slot gacor terpercaya dengan peluang kena scatter yang sangat mudah. Nikmati sensasi bermain kantin slot online dengan link login resmi yang cepat dan aman. Saatnya raih jackpot besar setiap hari!
- Cord Project — Cord is incredibly simple, incredibly fast voice messaging that lets you chat with one friend or shout to a whole group of friends. Start chatting for free on iPhone or Android now.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 416
- Round size: Series A $3.2M–$75M; Series B $8M–$115M; Series C $6M–$95M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Grockit — Grockit is a pioneering online social learning company. Grockit has proven that people learn more, faster through combining social learning mechanics and multi-media learning content to help people teach and learn from others. Grockit.com offers Test Prep services for GMAT, IIM CAT, LSAT, GRE, ACT, SAT and AP Calculus and AP History tests.Grockit has built a social learning test prep platform for license and direct-to-consumer products. Florida Virtual Schools, KIPP Schools, Georgetown University and other schools have deployed Grockit services.
- IFM Therapeutics — IFM Therapeutics is a provider of small molecule that module novel targets in the innate immune system. The company and its academic collaborators combine unparalleled expertise in innate immunity with seasoned drug discovery and development professionals. Its subsidiary IFM Due is focused on the discovery and developing antagonists of thecGAS/STING pathway for the treatment of inflammation, neuroinflammation, autoimmunity and cancer. IFM Discovery, a newly financed incubator entity within the IFM enterprise, is prosecuting a basket of genetically-validated targets as next-generation therapies for inflammation, neuroinflammation, autoimmunity and fibrosis
- Lifordi Immunotherapeutics — Lifordi is among the first companies to leverage the success of antibody-drug conjugates (ADC) to develop treatments for autoimmune and inflammatory disorders.
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 512
- Round size: Seed $1.8M–$22M; Series A $7M–$70M; Series B $13M–$150M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $100M in 2007
Portfolio highlights
- Clarifai — Clarifai is the leading Machine Learning, Computer Vision, NLP Platform. Label, train, deploy models on one AI platform for developers & data scientists.
- Shapeways — Shapeways is the #1 online 3D printing service company. Working with over a million customers since 2007 - Get 3D products and parts delivered to over 100 countries.
- Primer — Primer makes powerful mission-ready AI software designed to work in your environment, on your data. We help national security teams sift through massive unstructured data sets to find the needle in the haystack, understand and visualize their data, and act collaboratively. Our mission is to empower decisions that can be defended, and acted upon confidently.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 121
- Round size: Seed $1.3M–$7.3M; Pre-Seed $478k–$2.7M; Series A $6M–$18M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
- Leaders21com — They offer our customers an exciting portfolio of practical training and services. Based on our many years of experience and our specially developed leadership approach. Flexibility and situational action are essential leadership qualities. That is why we also structure our cooperation with our customers in exactly the same way - flexible andadapted to individual requirements. Digital and analog.
- The Joy Club — The Joy Club offers online activities, events, classes, and experiences for elderly people to remove loneliness.
First Round is a seed-stage venture firm focused on building a vibrant community of technology entrepreneurs and companies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 799
- Round size: Seed $1.1M–$8.4M; Series A $2.1M–$25M; Series B $7M–$60M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Rillet — Rillet automates majority of month-end close and offers powerful GAAP and SaaS reporting. The software has built-in revenue recognition, invoicing, and AI-powered accounting.
- PullString — PullString, Inc. is leading the field of computer conversation in both text and voice through a combination of design and technology. PullString (formerly ToyTalk) is an entertainment and technology company combining art and science to enable computer conversation with characters.The company's primary product, the PullString Platform, offersa professional authoring environment, hosted AI and machine learning runtime, and integrated conversation analytics to enterprises, agencies, and startups across verticals as diverse as entertainment, customer service, gaming and VR, travel, automotive, health and fitness, finance, human resources, and IoT.With direct support for all major conversational platforms like Facebook Messenger, Amazon Alexa, Skype, Slack, Kik, mobile, and web, the PullString Platform has been used to create award winning experiences like Call of Duty’s Lt Reyes on Messenger, Hello Barbie, and The Winston Show.PullString, founded as ToyTalk in 2011, has raised more than $44 million in funding from Greylock Partners; Charles River Ventures; Khosla Ventures; True Ventures; and First Round Capital.
- Blue Apron — Blue Apron is a New York-based start-up that is changing the way people cook at home. Blue Apron's weekly subscription service delivers everything you need to make fresh meals, including shopping for its customers at wholesale and delivering all the ingredients in specific proportions, along with printed recipe cards. The model aims to emulatehaving your own private chef-- subscribers will discover new recipes, eat fresher food, and save both time and money.
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 652
- Round size: Series A $5M–$40M; Series B $7.8M–$75M; Series C $7.1M–$55M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $100M in 2024
Portfolio highlights
- Lev — Save time, get great rates, and eliminate the paperwork on your next commercial real estate loan. Lev gets you financing in as little as 30 days.
- Dusty Robotics — Dusty Robotics builds robot-powered tools for the modern construction workforce.
- Savvy — Savvy is a software development company that engages in cybersecurity.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SV Angel is a service organization, investing in founders who share these values. They support entrepreneurs in building lasting companies by assisting at key inflection points and leveraging networks to help them propel their businesses forward.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 943
- Round size: Seed $1M–$9.2M; Series A $2.5M–$35M; Series B $8M–$107M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $29M in 2022
Portfolio highlights
- Hyperpublic — Hyperpublic is an open database of people, places, and things tied to a specific location. Anyone can add objects to the database and developers will be able to build applications on top of the data.
- Pomelo Care — Pomelo is a virtual maternity care program that supplements traditional pregnancy care with unlimited, customized support. Ask a dietitian about prenatal vitamins, speak to a therapist about labor anxiety, or join a prenatal group. Become a member today for free.
- Terra Industries — Terra Industries develops autonomous security systems and software platforms that support the monitoring and protection of physical assets, infrastructure, and operational environments across land, air, and maritime domains. The company provides unmanned vehicles, autonomous towers, and sensor-based surveillance hardware that collect and transmitdata for continuous situational awareness. Its software layer, built around an integrated operating system, processes sensor inputs, applies artificial intelligence models, and coordinates automated responses to detected events. Terra Industries designs its systems to support functions such as perimeter security, infrastructure monitoring, asset tracking, and threat detection within complex operational settings. The company’s platforms enable operators to manage multiple autonomous devices through a unified interface that supports mission planning, data visualization, and system control. Its technology is used by organizations that require coordinated security, monitoring, and response capabilities for facilities, remote sites, and distributed operations.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 428
- Round size: Series B $26M–$152M; Series C $40M–$200M; Post-IPO Equity $30M–$235M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
- Capstan Therapeutics — Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 495
- Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
- Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
- Digital Learning Institute — Become a certified digital learning professional with globally recognized, industry-approved instructional design courses at Digital Learning Institute.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 156
- Round size: Seed $1.6M–$20M; Series A $1.9M–$42M; Series B $3M–$73M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- Ruoyi Biotech — Ruoyi Biotech is a developer of macromolecular drug delivery technology.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1859
- Round size: Seed $1.5M–$10M; Series A $4.4M–$40M; Series B $10M–$70M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $14M in 2019
Portfolio highlights
- migme — Migme Limited is a global digital media company focused on emerging markets offers migme, a fan-based social entertainment platform that offers chat, content, and microblogging services. It enables users to post bite-sized blogs, send messages, and exchange virtual gifts with each other.The site’s revenue is generated via gifts, games, avataritems, emoticons, and stickers.Migme Limited was founded in 2005 and is listed and registered in Australia, with headquarters in Singapore.
- Port — Port allows DevEx teams to build a catalog of assets empowering everyone to perform self-service actions
- Shift Technology — Shift Technology delivers AI-native decision automation and optimization solutions built specifically for the global insurance industry. Addressing several critical processes across the insurance policy lifecycle, Shift helps insurers achieve faster, more accurate claims and policy resolutions. Shift has analyzed billions of insurance transactionsto date and was presented Frost & Sullivan’s 2020 Global Claims Solutions for Insurance Market Leadership Award.
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 777
- Round size: Seed $1.5M–$14M; Series A $5.5M–$43M; Series B $15M–$105M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Year & Day — Shop Modern Table Settings at Year & Day, your source for modern dinnerware and table settings. Find ceramic plates, bowls, flatware and glass online today.
- Modumetal — Modumetal has enabled a revolutionary new class of nanolaminated materials with broad application in structural, corrosion and high temperature performance of coatings, bulk materials and partsModumetal is based on the interaction of different materials at their interfaces. By laminating metals, Modumetal creates a new way to influence materialproperties. By growing metal using low-cost electrochemical methods, Modumetal enables a whole new class of applications of these materials.Modumetal is currently producing nanolaminated alloys for applications in construction, energy and aerospace markets.
- Workstream — Workstream is an automated hiring platform that helps companies employing hourly workers. The platform helped Jamba, Chick-fil-A, McDonald's, Dunkin', Applebee's, Auntie Anne's, Cinnabon to increase their bottom line and cost savings.Workstream was founded in 2017 and is headquartered in San Francisco, California, UnitedStates.
Over the past two decades, GFC have backed over five hundred entrepreneurs worldwide, e.g. Facebook, LinkedIn, Slack, and Away Travel.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 822
- Round size: Seed $1.4M–$8.8M; Pre-Seed $637k–$5M; Series A $4M–$33M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $2B in 2018
Portfolio highlights
- TalentHack — TalentHack is a health platform that connects directly with the fitness professionals and industry. They exist to redefine what a career in fitness can be, by providing opportunities to propel you forward. It takes hours for companies to find a single potential lead, let alone a candidate. The company was founded in 2018 and is based in New York,NY, United States
- Membrane — Membrane is AI for product integrations. Describe what you need, watch integrations build, test and maintain themselves.We exist to let any product connect to any other reliably, safely, and at scale, by turning intent & customer needs into integrations with AI.Our platform offers the state-of-the-art solution in the AI Age for productintegrations:Membrane Agent builds integrations for one or multiple apps at once, choosing correct API calls, field mappings, and data structuresMembrane Engine is the configurable infrastructure that you or any agent can play with. It contains actions, events/webhooks, flows, data collections, unified API models, field mappings, and schemas & more used to build and maintain integrations at scale.Membrane Packages - integration code that is purpose built for your use case, that you can deploy in your IDE.Membrane is used by 100+ B2B SaaS companies like Constant Contact, PandaDoc, Dialpad, Storyblok & many others as their preferred integration partner
- Bravo Sierra — Bravo Sierra creates performance body care products for the most active individuals. Every formula undergoes rigorous field-testing to meet strict standards of quality and efficacy. Designed and manufactured in the U.S.A, a portion of every purchase directly supports military veterans and their families.
BoxGroup is an early stage investment fund focused on technology companies. Contact Us: hello@boxgroup.com
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Canada
Investor stats
- Total investments: 528
- Round size: Seed $1.5M–$8.5M; Series A $5.5M–$31M; Series B $16M–$90M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Ansa — The closed loop platform built for your customers.
- David Energy — David Energy is an electricity provider that designs, builds, and manages onsite energy grids. The company empowers buildings with the tools needed to maximize onsite energy and bring transparency to a traditionally opaque, commoditized industry. It provides hands-on expertise and on the ground support, all delivered through its software platform.Founded in 2017, David Energy is headquartered in Brooklyn, New York.
- Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $100k–$2.5M; Grant $25k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- OmniSpeech — OmniSpeech develops AI-powered speech processing software that eliminates noise and improves voice intelligibility.
- Digital Harbor Foundation — Digital Harbor Foundation is comprised of people who love what they do and work hard day-in and day-out to make a difference in the lives of the youth they serve. They think hard about education, technology, and innovation, and work even harder to overcome the socio-economic barriers that impede forward progress for too many. They are not perfectbut they care about their work and give it everything they have every day.
- Howard County Library System — Howard County Library System is a public library systems that aims to deliver high-quality public education for all ages.
8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 471
- Round size: Seed $2.7M–$13M; Series A $7.4M–$55M; Series B $16M–$175M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- DataHub — DataHub Core is the #1 open source platform with a uniquely scalable and extensible metadata graph supporting manual and automated data management. DataHub Cloud is an enterprise-ready SaaS solution providing a fully-managed service of DataHub Core with additional AI-powered capabilities in discovery, observability, and governance to accelerateproduction-readiness of AI and data assets.
- Middleware — Middleware's observability platform gives you complete visibility into your tech stack to monitor and diagnose issues at scale with total control over your data.
- Flywheel.io — Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from topuniversities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT.Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Argentina
Investor stats
- Total investments: 180
- Round size: Seed $1.3M–$4.3M; Series A $347k–$15M; Series B $9M–$59M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $722k in 2022
Portfolio highlights
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- UnaliWear — The Kanega Watch is a wearable medical alert device and fall detection watch with voice activated help that you never have to remove to charge.
- Sandstone Diagnostics — Sandstone's Torq technology enables point-of-care clinical diagnostics and care by bringing the sample prep to the patient.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 129
- Round size: Seed $2.3M–$13M; Series A $3.8M–$74M; Series B $8.8M–$80M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 210
- Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
- Rgenta Therapeutics — Our mission is to develop RNA-targeting medicines to treat previously incurable diseases
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 224
- Round size: Series A $9M–$84M; Series B $20M–$116M; Series C $12M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $850M in 2021
Portfolio highlights
- Orna Therapeutics — Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
- Werewolf Therapeutics — Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
FJ Labs is a stage-agnostic investment firm that focuses on marketplaces and consumer facing startups.
Show more...Investment focus
- Industry: Software, E-Commerce, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, United Kingdom
Investor stats
- Total investments: 867
- Round size: Seed $1.4M–$10M; Series A $4.4M–$27M; Series B $12M–$65M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $5.5M in 2016
Portfolio highlights
- POC Pharma — POC Pharma is a SaaS company helping the stakeholders in the Pharmacy Channel to digitally manage their go to market strategy.
- Double — Double combines a dedicated human assistant and the best software to help you achieve what matters most.
- Clutch — Clutch is a Toronto-based technology company that is reinventing the way people buy and own cars. Clutch offers high-quality certified vehicles at great prices through a fully online customer experience. At Clutch.ca, customers browse inventory online, buy the car that’s right for them, and enjoy effortless at-home delivery. Clutch’s mission is toprovide customers with a delightful car buying experience by offering high-quality cars at great prices with ultimate convenience while making a positive impact on the communities in which it operates.
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 145
- Round size: Series A $17M–$102M; Series B $11M–$150M; Series C $14M–$146M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- CytomX Therapeutics — CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
- Agios Pharmaceuticals — Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. This foundation will remain constant at Agios and accelerate our impact moving forward.
- Synnovation Therapeutics — Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 165
- Round size: Seed $2.4M–$21M; Series A $5.6M–$46M; Series B $15M–$100M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
- Prexton Therapeutics — Voici la page d'accueil du site web
5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries. 5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 174
- Round size: Series A $13M–$70M; Series B $16M–$110M; Series C $14M–$100M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $450M in 2022
Portfolio highlights
- Neurogastrx — Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.
- Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
- Radionetics Oncology — Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications, is poised to capitalize on the increasing demand for novel radiotherapeutics.
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Canada
Investor stats
- Total investments: 118
- Round size: Seed $200k–$2.5M; Series A $3M–$40M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $20M in 2002
Portfolio highlights
- Latus Bio — Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
- Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
- Vittoria Biotherapeutics — Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Health Care VC funding at a glance
Stats across 66k deals from 26k investors.
Access all 25681 VC funds in Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 25681 VC funds investing in Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!